These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6682772)

  • 21. Synthesis and characterization of magnetically responsive albumin microspheres containing cis-hydroxyproline for scar inhibition.
    Iannotti JP; Baradet TC; Tobin M; Alavi A; Staum M
    J Orthop Res; 1991 May; 9(3):432-44. PubMed ID: 2010848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxorubicin and vincristine with methionine depletion contributed to survival in the Yoshida sarcoma bearing rats.
    Nagahama T; Goseki N; Endo M
    Anticancer Res; 1998; 18(1A):25-31. PubMed ID: 9568051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combinations.
    Eichler G; Habs M; Schmähl D
    J Cancer Res Clin Oncol; 1983; 105(3):250-7. PubMed ID: 6406513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres.
    Liu Z; Ballinger JR; Rauth AM; Bendayan R; Wu XY
    J Pharm Pharmacol; 2003 Aug; 55(8):1063-73. PubMed ID: 12956895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition.
    Cummings J; Willmott N; Marley E; Smyth J
    Biochem Pharmacol; 1991 Jun; 41(12):1849-54. PubMed ID: 2039540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experiment and clinical application of targeting treatment with adriamycin magnetic albumin microspheres in human gastric carcinoma].
    Tao K; Chen D; Wang G; Bai Z; Lu X; Tian Y; Wu Z; Hu F; Nie X
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):205-7. PubMed ID: 11829819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiopharmaceutical tracking of particles injected into tumors: a model to study clearance kinetics.
    Luboldt W; Pinkert J; Matzky C; Wunderlich G; Kotzerke J
    Curr Drug Deliv; 2009 Jul; 6(3):255-60. PubMed ID: 19604139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted modulation of acute inflammation.
    Ranney DF
    Science; 1985 Jan; 227(4683):182-4. PubMed ID: 3966151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
    Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
    Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased anti-tumor effect of adriamycin-loaded albumin microspheres is associated with anaerobic bioreduction of drug in tumor tissue.
    Willmott N; Cummings J
    Biochem Pharmacol; 1987 Feb; 36(4):521-6. PubMed ID: 3827939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres.
    Widder KJ; Senyei AE; Ranney DF
    Cancer Res; 1980 Oct; 40(10):3512-7. PubMed ID: 7438037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization and distribution of magnetic chemotherapeutic drugs with magnetic targeting in rat brain.
    Li AM; Zhang CX; Fu XP; Zhang ZW; Xue QH; Yan RM; Yi LH
    Chin Med J (Engl); 2005 May; 118(10):824-7. PubMed ID: 15989762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusions.
    Emerich DF; Snodgrass P; Lafreniere D; Dean RL; Salzberg H; Marsh J; Perdomo B; Arastu M; Winn SR; Bartus RT
    Pharm Res; 2002 Jul; 19(7):1052-60. PubMed ID: 12180539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ultrastructural changes in the liver of rats with a Yoshida tumor under exposure to cyclophosphamide].
    Stoichkova N; Damianov B; Astardzhieva Z
    Vopr Onkol; 1979; 25(6):88-92. PubMed ID: 462878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy of murine Ehrlich carcinoma and rat Yoshida sarcoma transplanted on hamsters].
    Ondrus B; Oravec C; Cambelová J; Mériová M
    Bratisl Lek Listy; 1970 Sep; 54(3):262-74. PubMed ID: 5475862
    [No Abstract]   [Full Text] [Related]  

  • 36. Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration.
    Kerr DJ; Willmott N; McKillop JH; Cummings J; Lewi HJ; McArdle CS
    Cancer; 1988 Sep; 62(5):878-83. PubMed ID: 3409170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomedical applications of magnetic fluids. i. Magnetic guidance of ferro-colloid-entrapped albumin microsphere for site specific drug delivery in vivo.
    Morimoto Y; Sugibayashi K; Okumura M; Kato Y
    J Pharmacobiodyn; 1980 May; 3(5):264-7. PubMed ID: 7411389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biocompatible magnetic and molecular dual-targeting polyelectrolyte hybrid hollow microspheres for controlled drug release.
    Du P; Zeng J; Mu B; Liu P
    Mol Pharm; 2013 May; 10(5):1705-15. PubMed ID: 23506444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic microspheres: a model system of site specific drug delivery in vivo.
    Widder KJ; Senyel AE; Scarpelli GD
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):141-6. PubMed ID: 674215
    [No Abstract]   [Full Text] [Related]  

  • 40. [Strain of Yoshida sarcoma with induced pafencil resistance].
    Khomchenovskiĭ EI; Burova GF
    Biull Eksp Biol Med; 1985 Apr; 99(4):479-81. PubMed ID: 3986376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.